MARKET

CORBF

CORBF

Global Cord Bloo
EXMKT
1.250
+0.020
+1.63%
Closed 09:33 05/20 EDT
OPEN
1.250
PREV CLOSE
1.230
HIGH
1.250
LOW
1.250
VOLUME
200
TURNOVER
250
52 WEEK HIGH
3.590
52 WEEK LOW
0.611
MARKET CAP
167.39M
P/E (TTM)
1.922
1D
5D
1M
3M
1Y
5Y
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors
A class action lawsuit has been filed on behalf of those who acquired Global Cord Blood Corporation securities. Investors have until June 24, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The lawsuit alleges that Global Cord made false and/or misleading statements. The price of Global Cord shares declined after the company's acquisition of Cellenkos.
Barchart · 14h ago
Weekly Report: what happened at CORBF last week (0513-0517)?
Weekly Report · 19h ago
Weekly Report: what happened at CORBF last week (0506-0510)?
Weekly Report · 05/13 12:00
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)
Glancy Prongay & Murray LLP reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors of Global Cord Blood Corporation. Investors who purchased or otherwise acquired Global Cord blood corporation securities between June 4, 2019 and May 3, 2022 have a chance to be a putative lead plaintiff in this class action. Global Cord announced in April 2022 that it planned to acquire Cellenkos Inc. For $1 billion.
Barchart · 05/08 09:00
CO Stockholders with Significant Losses Should Contact Robbins LLP for Information About the Global Cord Blood Corporation Securities Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of Global Cord Blood Corporation (NYSE: CO) shareholders. The class action alleges that the board of global cord blood corporation engaged in self-serving and conflicted transactions. Global cord blood provides umbilical cord blood storage and services in China.
Barchart · 05/07 17:03
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)
Law Offices of Howard G. Smith reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the case of Global Cord Blood Corporation. Investors who purchased Global Cord blood Corporation securities between June 4, 2019 and May 3, 2022 are encouraged to contact the Law Offices. Global Cord announced it planned to acquire Cellenkos Inc. For $1 billion.
Barchart · 05/07 13:57
Weekly Report: what happened at CORBF last week (0429-0503)?
Weekly Report · 05/06 12:10
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors
A class action lawsuit has been filed on behalf of Global Cord Blood Corporation shareholders. Global Cord investors have until June 21, 2024 to file a lead plaintiff motion. The Law Offices of Frank R. Cruz says the company's stock price fell after it agreed to acquire Cellenkos for over $1 billion.
Barchart · 05/06 11:06
More
About CORBF
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Webull offers Global Cord Blood Corp stock information, including EXMKT: CORBF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORBF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORBF stock methods without spending real money on the virtual paper trading platform.